# Safety and Efficacy of NT 201, Free of Complexing Proteins, in the Treatment of Glabellar Frown Lines

> **NCT00694148** · PHASE3 · COMPLETED · sponsor: **Merz Pharmaceuticals GmbH** · enrollment: 108 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** NT 201

## Key facts

- **NCT ID:** NCT00694148
- **Lead sponsor:** Merz Pharmaceuticals GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-05
- **Primary completion:** 2009-01
- **Final completion:** 2009-01
- **Target enrollment:** 108 (ACTUAL)
- **Last updated:** 2012-10-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00694148

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00694148, "Safety and Efficacy of NT 201, Free of Complexing Proteins, in the Treatment of Glabellar Frown Lines". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT00694148. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*